Stock screenerAll disclosures →
EDGAR →
NVS
Conviction 68HealthcareScan · Tue, Sep 8, 2026NVS$137.74-13.91%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 2.71M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price137.74
Change-13.91%
Gap-12.57%
Rel volume7.76×
Avg volume2.36M
Avg $ vol358.81M
SMA 20155.60
SMA 50155.27
SMA 200149.77
Price vs 50-11.29%
Price vs 200-8.03%
MA stackmixed
50/200 cross—
Supertrenddown · 155.15
RSI (14)32
MACD hist-0.97
MACD crossbear · 0d
Stoch %K / %D2 / 52
ADX (14)18
+DI / −DI24 / 47
RSI divergence—
MACD divergence—
ATR %+3.49%
ADR %1.53%
52w high168.62
52w low121.80
From 52w high-18.31%
Above 52w low+13.09%
New 52w highNo
SqueezeOff
Bollinger width14.26%
%B-0.31
Donchian pos2.28%
Donchian high164.48
Donchian low137.12
AVWAP (52w high)152.90
vs AVWAP high-9.91%
AVWAP (52w low)149.25
vs AVWAP low-7.71%
OBV trendDown
Chaikin MF (20)-0.20
Today vs 20d7.76×
Avg vol (14d)2.71M
Avg vol (20d)2.36M
Avg $ vol (20d)358.81M
Market cap262.83B
RS 3m (vs SPY)+2.84%
RS 6m (vs SPY)-14.63%
RS line new highNo
Trend template5/8
Technical rank14.8
1 week-9.42%
1 month-11.89%
3 months-5.93%
6 months-15.39%
1 year+6.17%
YTD-0.58%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target164.31
Target upside19.29%
Analyst ratingBuy
Institutional6.84%
Ent. value262.83B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out2.03B
Employees75.27K
ListedThu, Nov 7, 1996
Free float1.86B
Float %97.7%
Short interest4.99M
Days to cover3.4d
Short volume53.5%
Squeeze score42 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.41 vs $2.20
Last surprise+9.6% beat
Setup gradeB
Conviction68 / 100
Pattern quality—
Tech rank14.8 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance162.65
Support149.21
Days since event—
Candle confirm—
News sentiment—
Recent news
- Novartis Stock Falls 12% on Its Third Trial Setback In a WeekYahoo Finance · Tue, Sep 8, 2026
- Novartis Is Having a Very Bad September—and More Pain Could Be on the WayYahoo Finance · Tue, Sep 8, 2026
- Novartis pelacarsen Lp(a) trial fails, raising doubts for Amgen, LillyQz · Tue, Sep 8, 2026
- Fortis Healthcare to Install India's First Upright Proton Therapy System, Advancing Precision Cancer CareYahoo Finance · Tue, Sep 8, 2026
- 5 Things to Know Before the Stock Market Opens on TuesdayInvestopedia · Tue, Sep 8, 2026
- Why Novartis’ Drug Trial Results Are Blowing Up Amgen StockYahoo Finance · Tue, Sep 8, 2026
- Novartis Stock Drops as Trial Failures Ripple Across Biotech PartnersYahoo Finance · Tue, Sep 8, 2026
- Novartis del-desiran drug trial fails, stock drops 9%Qz · Tue, Sep 8, 2026
- The Stock Market Has Ignored the Iran Conflict. Why That’s About to Change.Yahoo Finance · Tue, Sep 8, 2026
- BMO lowers Amgen, BioNTech to Market Perform as risk-reward shiftsYahoo Finance · Tue, Sep 8, 2026
Congress activity
Disclosed STOCK Act trades in NVS · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Alan Armstrong senate · R · OK · traded 2026-03-31 | Buy | $1K–$15K | 2026-03-31 | 2026-07-21 | |
Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $15K–$50K | 2026-03-30 | 2026-07-21 | |
 Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
Lisa McClain house · R · MI · traded 2025-09-25 | Sell | $1K–$15K | 2025-09-25 | 2025-10-22 | |
Lisa McClain house · R · MI · traded 2025-09-11 | Buy | $1K–$15K | 2025-09-11 | 2025-10-22 | |
Lisa McClain house · R · MI · traded 2025-07-22 | Sell | $1K–$15K | 2025-07-22 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-10 | Sell | $1K–$15K | 2025-06-10 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Buy | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-11 | Buy | $1K–$15K | 2025-06-11 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-09 | Buy | $1K–$15K | 2025-06-09 | 2025-08-13 |
Insider activity
SEC Form 4 transactions in NVS
No recent insider (Form 4) filings in NVS. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in NVS · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.